{"slideshow_credits": null, "snippet": "J. Michael Pearson stepped down amid a series of investigations into Valeant\u2019s business practices.", "abstract": "Valeant Pharmaceuticals announces former chief executive J Michael Pearson will receive $9 million severance payment and will continue on in capacity of consultant until end of 2017; Pearson left company due to number of investigations into company's business practices.", "section_name": "Business Day", "print_page": "2", "document_type": "article", "byline": {"person": [{"firstname": "Katie", "role": "reported", "lastname": "THOMAS", "rank": 1, "organization": ""}], "original": "By KATIE THOMAS"}, "web_url": "http://www.nytimes.com/2016/06/01/business/c-michael-pearson-former-valeant-chief-to-receive-9-million-severance.html", "lead_paragraph": "J. Michael Pearson stepped down amid a series of investigations into Valeant\u2019s business practices.", "headline": {"main": "Valeant\u2019s Former C.E.O. to Receive $9 Million Severance", "print_headline": "Valeant\u2019s Ex-Chief Is Given $9 Million in Severance Pay"}, "_id": "574db35738f0d826276783fa", "word_count": "340", "multimedia": [{"height": 126, "url": "images/2016/06/01/business/01valeant/01valeant-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2016/06/01/business/01valeant/01valeant-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 400, "url": "images/2016/06/01/business/01valeant/01valeant-articleLarge.jpg", "legacy": {"xlarge": "images/2016/06/01/business/01valeant/01valeant-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2016/06/01/business/01valeant/01valeant-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/06/01/business/01valeant/01valeant-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2016-06-01T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "organizations", "value": "Valeant Pharmaceuticals International Inc", "is_major": "Y", "rank": "1"}, {"name": "subject", "value": "Executive Compensation", "is_major": "Y", "rank": "2"}, {"name": "persons", "value": "Pearson, John Michael (1959- )", "is_major": "Y", "rank": "3"}, {"name": "organizations", "value": "Securities and Exchange Commission", "is_major": "N", "rank": "4"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "5"}], "blog": [], "subsection_name": null, "type_of_material": "News"}